Bedel Financial Consulting’s Avanos Medical AVNS Stock Holding History

Bedel Financial Consulting’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-319	Closed	-$11K	–	248
2022 Q1	$11K	Hold	319	–	–	﹤0.01%	640
2021 Q4	$11K	Hold	319	–	–	﹤0.01%	668
2021 Q3	$10K	Sell	319 -2	-0.6%	-$68	﹤0.01%	662
2021 Q2	$12K	Buy	321 +2	+0.6%	+$83	﹤0.01%	633
2021 Q1	$14K	Buy	319 +30	+10%	+$1.41K	0.01%	574
2020 Q4	$13K	Hold	289	–	–	0.01%	509
2020 Q3	$10K	Hold	289	–	–	0.01%	515
2020 Q2	$8K	Hold	289	–	–	﹤0.01%	516
2020 Q1	$8K	Hold	289	–	–	0.01%	501
2019 Q4	$10K	Sell	289 -11	-4%	-$398	0.01%	501
2019 Q3	$11K	Hold	300	–	–	0.01%	463
2019 Q2	$13K	Hold	300	–	–	0.01%	445
2019 Q1	$13K	Hold	300	–	–	0.01%	447
2018 Q4	$13K	Hold	300	–	–	0.01%	419
2018 Q3	$18K	Hold	300	–	–	0.01%	391
2018 Q2	$17K	Hold	300	–	–	0.01%	396
2018 Q1	$14K	Buy	+300	New	+$14.2K	0.01%	424

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Bedel Financial Consulting's AVNS Position: Q2 2022 in Review

Bedel Financial Consulting sold out of Avanos Medical (AVNS) in Q2 2022, closing a stake of 319 shares — an estimated $11K sold.

Bedel Financial Consulting first reported a position in AVNS in Q1 2018 and held it in 17 quarters. The position peaked at $18K in Q3 2018. 287 funds tracked by Wall St. Rank hold AVNS as of Q2 2022.

Bedel Financial Consulting reported no remaining Avanos Medical position as of Q2 2022 after selling out during the quarter.
Bedel Financial Consulting sold 319 Avanos Medical shares in Q2 2022, an estimated $11K.
Bedel Financial Consulting first reported a position in Avanos Medical in Q1 2018 and held it in 17 quarters.
Bedel Financial Consulting's Avanos Medical position peaked at $18K in Q3 2018.
287 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2022.

Based on Bedel Financial Consulting's 13F filing for Q2 2022, filed 4 Aug 2022.